Log In
BCIQ
Print this Print this
 

MEDI8111

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionRecombinant human Factor II
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule
Latest Stage of DevelopmentPhase I
Standard IndicationBleeding
Indication DetailsTreat trauma and bleeding
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today